News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,919 Results
Type
Article (14264)
Company Profile (105)
Press Release (259542)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88290)
Career Advice (468)
Deals (15395)
Drug Delivery (73)
Drug Development (36715)
Employer Resources (50)
FDA (6386)
Job Trends (6234)
News (150726)
Policy (14132)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (443)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23320)
ALS (56)
Alzheimer's disease (478)
Antibody-drug conjugate (ADC) (99)
Approvals (6577)
Artificial intelligence (201)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (172)
Cancer (1318)
Cardiovascular disease (151)
Career advice (421)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32024)
Collaboration (726)
Compensation (327)
Complete response letters (33)
COVID-19 (778)
CRISPR (43)
C-suite (434)
Cystic fibrosis (58)
Data (1829)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1383)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (81)
Earnings (33468)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (38982)
Executive appointments (529)
FDA (7486)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (429)
Gene editing (70)
Generative AI (18)
Gene therapy (167)
GLP-1 (439)
Government (1405)
Grass and pollen (4)
Guidances (164)
Healthcare (3578)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (842)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5917)
IRA (33)
Job creations (2057)
Job search strategy (376)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3448)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1307)
Medtech (1314)
Mergers & acquisitions (9900)
Metabolic disorders (434)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (37)
Neuroscience (887)
Neurotech (1)
NextGen: Class of 2026 (1591)
Non-profit (600)
Now hiring (17)
Obesity (227)
Opinion (141)
Ovarian cancer (39)
Pain (117)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (118)
Peanut (12)
People (29755)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8307)
Phase 2 (13522)
Phase 3 (12211)
Pipeline (1912)
Policy (135)
Postmarket research (1401)
Preclinical (3338)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (136)
Rare diseases (351)
Real estate (2659)
Recruiting (18)
Regulatory (10960)
Reports (15)
Research institute (575)
Resumes & cover letters (56)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (81)
Series B (48)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1645)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (32)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Today (3)
Last 7 days (174)
Last 30 days (659)
Last 365 days (10429)
2026 (956)
2025 (10734)
2024 (12523)
2023 (14253)
2022 (19563)
2021 (20076)
2020 (19036)
2019 (14899)
2018 (11713)
2017 (13895)
2016 (13130)
2015 (15474)
2014 (12420)
2013 (10598)
2012 (11399)
2011 (11925)
2010 (10889)
Location
Africa (321)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20892)
Australia (2690)
California (3195)
Canada (1482)
China (550)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40926)
Florida (607)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (348)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (421)
Massachusetts (2587)
Michigan (46)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1405)
New Mexico (7)
New York (906)
North Carolina (619)
North Dakota (2)
Northern California (1462)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (715)
Puerto Rico (12)
Rhode Island (17)
South America (511)
South Carolina (10)
Southern California (1387)
Tennessee (53)
Texas (454)
United States (12702)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (223)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
273,919 Results for "pmv pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 13, 2025
·
9 min read
Press Releases
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 8, 2025
·
8 min read
Press Releases
PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 14, 2025
·
3 min read
Press Releases
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 27, 2025
·
9 min read
Press Releases
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - May 23, 2025
May 26, 2025
·
1 min read
Press Releases
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
September 10, 2025
·
9 min read
Press Releases
PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights
May 9, 2025
·
8 min read
Press Releases
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
February 11, 2025
·
1 min read
Pharm Country
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
PMV Pharmaceuticals, Inc today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences in June.
May 30, 2024
·
1 min read
Press Releases
PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights
March 3, 2025
·
11 min read
1 of 27,392
Next
